The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Audio |
| Language: | English |
| Published: |
London :
Henry Stewart Talks,
2020.
|
| Series: | Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
|
| Subjects: | |
| Online Access: | https://hstalks.com/bs/4463/ Series |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag
Table of Contents:
- Contents: Mode of action of the Oxford/AstraZeneca RNA vaccine
- Two potential adverse events reported in patients enrolled in the vaccine's phase 3 trial
- Steps undertaken to determine possible causality between the adverse events and the vaccine
- Current status of the trial
- Please note that since the recording of this interview it was determined that "The serious adverse events observed during the trial in these study groups were judged to be unrelated to the study vaccines and occurred at frequencies expected for these conditions in the general population. None of the participants included in this report had any suspected unexpected serious adverse reactions." (Ramasamy et al., The Lancet, November 18, 2020, https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32466-1/fulltext).
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports / 
Media coverage of the COVID-19 vaccines in Kenya a case of the standard and the daily Nation newspapers